Friday, April 19

Tag: Cipla

Cipla acquired 22 percent stake in GoApptiv
11Jun By Press Trust of IndiaNo Comments
ACQUISITION

Cipla acquired 22 percent stake in GoApptiv

Pharma major Cipla will acquire 21.85 percent stake in GoApptiv on a fully-diluted basis in two phases. The cost of acquisition is Rs 9 crore (Rs 5.80 crore in the first stage and Rs 3.20 crore in the second stage), it said in a regulatory filing. In the first stage, subscription of 15,392 compulsorily convertible preference shares and purchase of 6,927 equity shares is expected to be closed within 30 days from the execution date, subject to certain conditions precedent,.In the second stage, subscription of 12,314 compulsorily convertible preference shares is expected to close by October 31, subject to certain conditions precedent, it added. GoApptiv offers digital solutions for integrated brand sales management, digital marketing and channel engagement for pharmaceutical compan...
Read More
Cipla’s Ugandan Unit Expects to Raise $45 million from IPO
15Aug By Gauri SinghNo Comments
Market

Cipla’s Ugandan Unit Expects to Raise $45 million from IPO

India’s pharmaceutical giant Cipla’s Ugandan unit is reportedly aiming to raise $45 million from initial public offering (IPO). The company priced its IPO at 256.5 shillings per share. This amount is expected to be raised from its listing on the Kampala stock exchange next month. Cipla Quality Chemical Industries is majority owned by India's third-largest drugmaker and is selling 657,179,319 shares or an 18 per cent stake in the company. In this regard, the company has stated that each of its shareholders would be “selling a minority of their stakes” in the IPO and also the transaction and potential listing had gained regulatory approvals. The company expressed as part of its growth strategy, it “has been evaluating an initial public offering and listing of its issued share capital ...
Read More